Inhibidores del EGFR: ¿qué pacientes se benefician de estos fármacos?
Leído
15148
Vecesse ha leído el artículo
14023
Total PDF
1125
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 36 | 120 | 156 |
| 2025 11 | 17 | 187 | 204 |
| 2025 10 | 6 | 113 | 119 |
| 2025 9 | 17 | 113 | 130 |
| 2025 8 | 21 | 148 | 169 |
| 2025 7 | 22 | 128 | 150 |
| 2025 6 | 17 | 149 | 166 |
| 2025 5 | 16 | 147 | 163 |
| 2025 4 | 11 | 165 | 176 |
| 2025 3 | 39 | 207 | 246 |
| 2025 2 | 20 | 160 | 180 |
| 2025 1 | 15 | 198 | 213 |
| 2024 12 | 5 | 186 | 191 |
| 2024 11 | 11 | 224 | 235 |
| 2024 10 | 5 | 244 | 249 |
| 2024 9 | 8 | 218 | 226 |
| 2024 8 | 4 | 190 | 194 |
| 2024 7 | 14 | 199 | 213 |
| 2024 6 | 8 | 229 | 237 |
| 2024 5 | 5 | 320 | 325 |
| 2024 4 | 11 | 177 | 188 |
| 2024 3 | 12 | 240 | 252 |
| 2024 2 | 4 | 229 | 233 |
| 2024 1 | 10 | 244 | 254 |
| 2023 12 | 6 | 213 | 219 |
| 2023 11 | 5 | 299 | 304 |
| 2023 10 | 7 | 346 | 353 |
| 2023 9 | 7 | 185 | 192 |
| 2023 8 | 13 | 204 | 217 |
| 2023 7 | 8 | 271 | 279 |
| 2023 6 | 13 | 248 | 261 |
| 2023 5 | 30 | 337 | 367 |
| 2023 4 | 33 | 249 | 282 |
| 2023 3 | 16 | 216 | 232 |
| 2023 2 | 10 | 158 | 168 |
| 2022 1 | 9 | 201 | 210 |
| 2022 12 | 7 | 170 | 177 |
| 2022 11 | 8 | 200 | 208 |
| 2022 10 | 11 | 208 | 219 |
| 2022 9 | 6 | 218 | 224 |
| 2022 8 | 6 | 162 | 168 |
| 2022 7 | 10 | 134 | 144 |
| 2022 6 | 7 | 161 | 168 |
| 2022 5 | 6 | 194 | 200 |
| 2022 4 | 11 | 172 | 183 |
| 2022 3 | 13 | 176 | 189 |
| 2022 2 | 4 | 139 | 143 |
| 2021 1 | 8 | 195 | 203 |
| 2021 12 | 5 | 154 | 159 |
| 2021 11 | 8 | 230 | 238 |
| 2021 10 | 4 | 176 | 180 |
| 2021 9 | 8 | 162 | 170 |
| 2021 8 | 6 | 110 | 116 |
| 2021 7 | 5 | 67 | 72 |
| 2021 6 | 6 | 67 | 73 |
| 2021 5 | 7 | 131 | 138 |
| 2021 4 | 19 | 203 | 222 |
| 2021 3 | 13 | 106 | 119 |
| 2021 2 | 7 | 89 | 96 |
| 2020 1 | 11 | 130 | 141 |
| 2020 12 | 4 | 103 | 107 |
| 2020 11 | 8 | 128 | 136 |
| 2020 10 | 6 | 92 | 98 |
| 2020 9 | 5 | 81 | 86 |
| 2020 8 | 7 | 59 | 66 |
| 2020 7 | 4 | 59 | 63 |
| 2020 6 | 5 | 55 | 60 |
| 2020 5 | 9 | 95 | 104 |
| 2020 4 | 3 | 86 | 89 |
| 2020 3 | 6 | 49 | 55 |
| 2020 2 | 4 | 52 | 56 |
| 2020 1 | 3 | 22 | 25 |
| 2019 12 | 7 | 36 | 43 |
| 2019 11 | 3 | 19 | 22 |
| 2019 10 | 2 | 28 | 30 |
| 2019 9 | 1 | 29 | 30 |
| 2019 8 | 0 | 21 | 21 |
| 2019 7 | 17 | 28 | 45 |
| 2019 6 | 15 | 97 | 112 |
| 2019 5 | 22 | 190 | 212 |
| 2019 4 | 10 | 96 | 106 |
| 2019 3 | 0 | 32 | 32 |
| 2019 2 | 2 | 41 | 43 |
| 2019 1 | 0 | 33 | 33 |
| 2018 12 | 3 | 30 | 33 |
| 2018 11 | 2 | 56 | 58 |
| 2018 10 | 5 | 39 | 44 |
| 2018 9 | 0 | 19 | 19 |
| 2018 8 | 3 | 97 | 100 |
| 2018 7 | 1 | 56 | 57 |
| 2018 6 | 0 | 39 | 39 |
| 2018 5 | 2 | 55 | 57 |
| 2018 4 | 1 | 58 | 59 |
| 2018 3 | 0 | 25 | 25 |
| 2018 2 | 1 | 51 | 52 |
| 2018 1 | 1 | 20 | 21 |
| 2017 12 | 0 | 29 | 29 |
| 2017 11 | 0 | 32 | 32 |
| 2017 10 | 1 | 23 | 24 |
| 2017 9 | 1 | 24 | 25 |
| 2017 8 | 1 | 21 | 22 |
| 2017 7 | 2 | 27 | 29 |
| 2017 6 | 1 | 55 | 56 |
| 2017 5 | 3 | 22 | 25 |
| 2017 4 | 5 | 23 | 28 |
| 2017 3 | 10 | 44 | 54 |
| 2017 2 | 5 | 33 | 38 |
| 2016 1 | 1 | 15 | 16 |
| 2016 12 | 8 | 7 | 15 |
| 2016 11 | 8 | 3 | 11 |
| 2016 10 | 11 | 8 | 19 |
| 2016 9 | 6 | 3 | 9 |
| 2016 8 | 8 | 1 | 9 |
| 2016 7 | 4 | 2 | 6 |
| 2016 6 | 0 | 9 | 9 |
| 2016 5 | 0 | 93 | 93 |
| 2016 4 | 0 | 71 | 71 |
| 2016 3 | 0 | 44 | 44 |
| 2016 2 | 0 | 26 | 26 |
| 2015 1 | 0 | 16 | 16 |
| 2015 12 | 0 | 17 | 17 |
| 2015 11 | 0 | 28 | 28 |
| 2015 10 | 0 | 23 | 23 |
| 2015 9 | 0 | 14 | 14 |
| 2015 8 | 0 | 1 | 1 |
| 2015 6 | 0 | 1 | 1 |
| 2015 4 | 0 | 1 | 1 |
| 2015 2 | 1 | 2 | 3 |
| 2015 1 | 4 | 3 | 7 |
| 2014 12 | 3 | 1 | 4 |
| 2014 11 | 5 | 1 | 6 |
| 2014 10 | 3 | 1 | 4 |
| 2014 9 | 5 | 1 | 6 |
| 2014 8 | 9 | 1 | 10 |
| 2014 7 | 7 | 1 | 8 |
| 2014 6 | 7 | 2 | 9 |
| 2014 5 | 11 | 1 | 12 |
| 2013 7 | 1 | 1 | 2 |
| 2013 6 | 5 | 0 | 5 |
| 2010 8 | 140 | 0 | 140 |
Mostrar todo
